Skip to main content
. 2019 Aug 22;24(17):3046. doi: 10.3390/molecules24173046

Figure 2.

Figure 2

Gene Ontology analysis. (a) Addition of Bevacizumab (Bev) to Temozolomide (TMZ) upregulated genes for extracellular matrix organization and immune response in IDH1-mutant U87 cells. (b) Addition of Bev to TMZ downregulated genes for cell cycle progression in IDH1-mutant U87 cells.